Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.

Solbrig MV, Fan Y, Hermanowicz N, Morgese MG, Giuffrida A.

Exp Neurol. 2010 Nov;226(1):231-41. doi: 10.1016/j.expneurol.2010.09.003. Epub 2010 Sep 9.

2.

Prospects for cannabinoid therapies in viral encephalitis.

Solbrig MV, Fan Y, Hazelton P.

Brain Res. 2013 Nov 6;1537:273-82. doi: 10.1016/j.brainres.2013.08.032. Epub 2013 Sep 7.

3.

Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.

Solbrig MV, Hermanowicz N.

J Neurovirol. 2008 May;14(3):252-60. doi: 10.1080/13550280802074521.

PMID:
18569459
4.

Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats.

Bortolato M, Bini V, Frau R, Devoto P, Pardu A, Fan Y, Solbrig MV.

Eur Neuropsychopharmacol. 2014 Jun;24(6):974-85. doi: 10.1016/j.euroneuro.2013.12.011. Epub 2014 Jan 18.

PMID:
24630433
5.

WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination.

Sun J, Fang Y, Chen T, Guo J, Yan J, Song S, Zhang L, Liao H.

Brain Res. 2013 Jan 23;1491:225-35. doi: 10.1016/j.brainres.2012.11.006. Epub 2012 Nov 10.

PMID:
23148948
6.

Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.

Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.

Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. Epub 2007 Jul 4.

PMID:
17644084
7.

Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.

Di Marzo V, Berrendero F, Bisogno T, González S, Cavaliere P, Romero J, Cebeira M, Ramos JA, Fernández-Ruiz JJ.

J Neurochem. 2000 Apr;74(4):1627-35.

8.

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis.

Marchalant Y, Brothers HM, Norman GJ, Karelina K, DeVries AC, Wenk GL.

Neurobiol Dis. 2009 May;34(2):300-7.

PMID:
19385063
9.

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

Molina-Holgado E, Vela JM, Arévalo-Martín A, Almazán G, Molina-Holgado F, Borrell J, Guaza C.

J Neurosci. 2002 Nov 15;22(22):9742-53.

10.

Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain.

Marchalant Y, Brothers HM, Wenk GL.

Mol Psychiatry. 2009 Dec;14(12):1068-9. doi: 10.1038/mp.2009.62. No abstract available.

11.

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.

Marchalant Y, Rosi S, Wenk GL.

Neuroscience. 2007 Feb 23;144(4):1516-22. Epub 2006 Dec 18.

12.

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.

Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A.

Glia. 2003 Jan 15;41(2):161-8.

PMID:
12509806
13.

Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.

Enayatfard L, Rostami F, Nasoohi S, Oryan S, Ahmadiani A, Dargahi L.

Neuromolecular Med. 2013 Sep;15(3):523-35. doi: 10.1007/s12017-013-8238-x. Epub 2013 Jun 21.

PMID:
23794089
14.

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, Strong R, Lutz B, Marsicano G, Roberts JL, Giuffrida A.

Eur J Neurosci. 2009 Jun;29(11):2177-86. doi: 10.1111/j.1460-9568.2009.06764.x. Epub 2009 May 21.

15.

The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia.

Fernández-López D, Pradillo JM, García-Yébenes I, Martínez-Orgado JA, Moro MA, Lizasoain I.

Stroke. 2010 Dec;41(12):2956-64. doi: 10.1161/STROKEAHA.110.599357.

PMID:
21115947
16.

Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.

Accorsi-Mendonça D, Almado CE, Dagostin AL, Machado BH, Leão RM.

Brain Res. 2008 Mar 20;1200:1-9. doi: 10.1016/j.brainres.2008.01.011. Epub 2008 Jan 16.

PMID:
18308297
17.

The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.

Hao MX, Jiang LS, Fang NY, Pu J, Hu LH, Shen LH, Song W, He B.

J Lipid Res. 2010 Aug;51(8):2181-90. doi: 10.1194/jlr.M001511. Epub 2010 Mar 20.

19.

Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.

Shivachar AC.

Biochem Pharmacol. 2007 Jun 15;73(12):2004-11. Epub 2007 Mar 24.

PMID:
17445778
20.

Supplemental Content

Support Center